Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021

HomeMedX Health CorpMedX Health Corp Completes the Design Phase of its Telemedicine Platform

MedX Health Corp Completes the Design Phase of its Telemedicine Platform

The Completion of the design phase will allow MedX’s scanning devices to be deployed in multiple points of service in North America and internationally

MedX Health Corp. announced that it has completed the design phase of its telemedicine platform which will allow MedX’s scanning devices to be deployed in multiple points of service in North America and internationally. The scanned images will be sent securely to dermatologists for remote assessment, allowing for accelerated referral for patients to an in-person consultation with a dermatologist for the treatment of suspicious cases.

Regarding this new milestone, Robert von der Porten, President and Chief Executive Officer of MedX commented, “We are very excited about reaching this important milestone with Blanc Labs as we believe that this telemedicine platform is a game-changer for MedX and its growth trajectory, and ultimately for people – no matter where they live – who will be able to get their moles and lesions accurately assessed by a dermatologist without having to endure lengthy wait times to determine if there is cancer present.”  He added, “It brings the advantages of telemedicine to the growing skin cancer problem, while offering the benefits of software as a service (SaaS). We are confident that the deployment of our system, which will be available early in 2018, will help reduce patient wait times, healthcare costs and mortality rates.”

On the new partnership: “Our partnership will allow us to continue to be innovators in building this platform. Skin cancer is a massive global issue and we see the telemedicine platform as a way to help dramatically reduce skin cancer’s human, financial and emotional toll,” concluded Dariush Zomorrodi, Blanc Lab’s Chief Innovation Officer

According to the Canadian Cancer Society, melanoma is the deadliest form of skin cancer but when caught early it is largely curable. Frequent skin screenings, early detection and a strong focus on prevention are all necessary to stop the rise in melanoma cases.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

By using this website you agree to accept Medical Device News Magazine Privacy Policy